Gene · 2348
Papers3,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma. | Biomark Res | 2025 | 40038575 | PubTator, text mining | PubMed |
| Reinventing chemotherapy. | Oncologist | 2025 | 40036587 | PubTator, text mining | PubMed |
| IMGN853 Induces Autophagic Cell Death in Combination Therapy for Ovarian Cancer. | Cancer Res Commun | 2025 | 40029935 | PubTator, text mining | PubMed |
| Mirvetuximab Soravtansine Induces Potent Cytotoxicity and Bystander Effect in Cisplatin-Resistant Germ Cell Tumor Cells. | Cells | 2025 | 39996761 | PubTator, text mining | PubMed |
| Lactose in human milk is associated with lower rates of infection during a drought. | Ann Hum Biol | 2025 | 39936580 | PubTator, text mining | PubMed |
| A mini-overview of antibody-drug conjugates in platinum-resistant ovarian cancer: A preclinical and clinical perspective. | Int J Biol Macromol | 2025 | 39922351 | PubTator, text mining | PubMed |
| Laboratory-developed tests and in vitro diagnostics: A regulatory overview for anatomic pathology. | Am J Clin Pathol | 2025 | 39912823 | PubTator, text mining | PubMed |
| Molecular dynamics study of functionalized carbon nanotube loaded with multiple doxorubicin targeted to folate receptor α. | J Mol Graph Model | 2025 | 39908587 | PubTator, text mining | PubMed |
| Correction to "Folate regulation of planar cell polarity pathway and F-actin through folate receptor alpha". | FASEB J | 2025 | 39831531 | PubTator, text mining | PubMed |
| NSD2 mediated H3K36me2 promotes pulmonary arterial hypertension by recruiting FOLR1 and metabolism reprogramming. | Cell Signal | 2025 | 39798773 | PubTator, text mining | PubMed |
| Folate-targeted nanoparticles for glutamine metabolism inhibition enhance anti-tumor immunity and suppress tumor growth in ovarian cancer. | J Control Release | 2025 | 39756690 | PubTator, text mining | PubMed |
| Computational insights into maternal environmental pollutants and folate pathway regulation. | Reprod Toxicol | 2025 | 39732410 | PubTator, text mining | PubMed |
| The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features. | Crit Rev Oncol Hematol | 2025 | 39732305 | PubTator, text mining | PubMed |
| A pilot study of transcriptomic preimplantation genetic testing (PGT-T): towards a new step in embryo selection? | Hum Reprod | 2025 | 39719045 | PubTator, text mining | PubMed |
| Intraoperative Molecular Imaging With Pafolacianine: Histologic Characteristics of Identified Nodules. | Clin Lung Cancer | 2025 | 39706717 | PubTator, text mining | PubMed |
| Expression-Dependent Tumor Pretargeting via Engineered Avidity. | Mol Pharm | 2025 | 39704255 | PubTator, text mining | PubMed |
| High Spatiotemporal Near-Infrared II Fluorescence Lifetime Imaging for Quantitative Detection of Clinical Tumor Margins. | Adv Sci (Weinh) | 2025 | 39652447 | PubTator, text mining | PubMed |
| Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers. | Gynecol Oncol | 2025 | 39631181 | PubTator, text mining | PubMed |
| The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial. | Ann Oncol | 2025 | 39617145 | PubTator, text mining | PubMed |
| Antibody-drug conjugates as targeted therapy for treating gynecologic cancers: update 2025. | Curr Opin Obstet Gynecol | 2025 | 39480912 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2348/papers?page=15